王怀璋,林焯唐.抗癌宝口服液治疗中晚期恶性肿瘤103例临床观察[J].中国中西医结合杂志,1997,(12):730-732 |
抗癌宝口服液治疗中晚期恶性肿瘤103例临床观察 |
Clinical Study on Effect of Kang’aibao Oral Liquid in Treating 103 Malignant Tunmor Patients |
免费下载全文 查看/发表评论 下载PDF阅读器 |
|
DOI: |
中文关键词: 中晚期恶性肿瘤 抗癌宝口服液 生存时间 生存质量 |
英文关键词:malignant tumor of middle or advanced stage Kangaibao oral liquid survival time quality of survival |
基金项目: |
|
摘要点击次数: 1445 |
全文下载次数: 1053 |
中文摘要: |
目的:观察中药抗癌宝口服液(简称抗癌宝)治疗中晚期恶性肿瘤临床效果。方法:103例患者随机分为抗癌宝观察组与化疗对照组,对两组疗效作比较。结果:观察组患者免疫功能,近期有效率(CR+PR),生存质量,1、2、3年生存期及中位生存时间,癌胚抗原下降水平,明显高于对照组,且有显著性差异。结论:抗癌宝具有抑制肿瘤生长,延长生存时间,提高生存质量之效。 |
英文摘要: |
Objective: To observe the clinical efficacy of Kangaihao oral liquid(KABOL), a Chinese herbal Preparation in treating malignant turmor of middle or advanced stage. Methods:A comparative study was done by observing the effect of 103 patients treated with KABOL, and another 90 patients treated with chemotherapy in the same period were taken as a control group for comparison. Results : The immunologic function, short-term effective rate(complete relieved rate and partial relieved rate), survival quality, 1-, 2-and 3-year survival rate, median suvival time,and the CEA declining rate of the KABOL group were significantly higher than thine of the control group. Conclusions: KABOL has the effects of inhibiting tumor growth, prolonging the survival time and improving the quality ofsurvival of tumor patient. |
关闭 |
|
|
|